基于颞浅动脉的可重复微导管通路港(ReMAP)在头颈癌动脉内化疗中的应用:病例报告系列
本文报告两例晚期头颈癌患者通过皮下植入的ReMAP系统接受重复动脉内化疗,评估操作可行性、安全性和临床结局并与传统技术比较。病例1为42岁男性晚期上颌窦癌,接受8次大剂量顺铂动脉内化疗无并发症,影像证实肿瘤完全消退;病例2为52岁女性下颌原发性骨内鳞状细胞癌,经颈外动脉鞘完成8次动脉内化疗后改用ReMAP完成4次,减少住院需求并实现肿瘤控制。结论认为ReMAP系统能安全有效地实施动脉内化疗并减轻患者负担。
要点
- 两例晚期头颈癌患者经皮下植入ReMAP完成重复动脉内化疗,操作可行且安全。
- 病例1接受8次大剂量顺铂动脉内化疗无并发症,影像证实肿瘤完全消退。
- 病例2经颈外动脉鞘完成8次后改用ReMAP完成4次,减少住院需求并实现肿瘤控制。
核心结论
- ReMAP系统能够安全有效地实施动脉内化疗,同时减轻患者负担。
研究设计与样本
- 病例报告系列,纳入两例晚期头颈癌患者,评估经皮下植入ReMAP行重复动脉内化疗的操作可行性、安全性和临床结局,并与传统技术比较。
主要发现
- 病例1为42岁男性晚期上颌窦癌,接受8次大剂量顺铂动脉内化疗无并发症,随访影像证实肿瘤完全消退。
- 病例2为52岁女性下颌原发性骨内鳞状细胞癌,经颈外动脉鞘完成8次动脉内化疗后,经ReMAP完成4次,减少了住院需求并实现肿瘤控制。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intra-arterial chemotherapy (IAC) can be highly effective for advanced head and neck cancers but often necessitates complex procedures and prolonged hospitalization. Herein, we demonstrate the utility of the repeatable microcatheter access port (ReMAP) system for streamlining IAC. METHODS: Two patients with advanced head and neck cancers underwent repeated IAC via a subcutaneously implanted ReMAP. Procedural feasibility, safety, and clinical outcomes were assessed and compared to conventional techniques. RESULTS: Case 1 involved a 42-year-old male with advanced maxillary sinus carcinoma who received eight IAC sessions of high-dose cisplatin without complications. Follow-up imaging confirmed complete tumor resolution. Case 2 was a 52-year-old female with primary intraosseous squamous cell carcinoma of the jaw who completed eight IAC sessions via an external carotid arterial sheath, then four sessions with the ReMAP, reducing inpatient requirements, and achieving tumor control. CONCLUSIONS: The ReMAP system enabled safe and effective IAC administration while reducing patient burden.
引用
- Makino W, Fuwa N, Matsumoto A, et al. Superficial Temporal Artery-Based ReMAP: A Case Report Series in Head and Neck Cancer Intra-Arterial Chemotherapy. Head Neck. 2025. PMID: 40444544. doi:10.1002/hed.28205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。